Xylem (NYSE:XYL – Get Free Report) had its price objective increased by research analysts at Royal Bank of Canada from $160.00 to $163.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has an “outperform” rating on the industrial products company’s stock. Royal Bank of Canada’s price target indicates a potential upside of 21.10% from the company’s previous close.
Other analysts also recently issued research reports about the stock. Citigroup boosted their price objective on shares of Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a report on Monday, April 8th. Stifel Nicolaus boosted their price target on Xylem from $157.00 to $170.00 and gave the stock a “buy” rating in a research note on Thursday, July 18th. Robert W. Baird raised their price objective on Xylem from $151.00 to $155.00 and gave the company an “outperform” rating in a research note on Friday, May 3rd. Argus boosted their target price on Xylem from $146.00 to $165.00 and gave the stock a “buy” rating in a research report on Wednesday, May 29th. Finally, Oppenheimer raised their price target on Xylem from $147.00 to $152.00 and gave the company an “outperform” rating in a research report on Friday, May 31st. Five equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat, Xylem currently has an average rating of “Moderate Buy” and an average price target of $144.67.
View Our Latest Stock Report on Xylem
Xylem Stock Performance
Xylem (NYSE:XYL – Get Free Report) last announced its quarterly earnings data on Tuesday, July 30th. The industrial products company reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. Xylem had a return on equity of 8.95% and a net margin of 8.34%. The firm had revenue of $2.17 billion for the quarter, compared to analyst estimates of $2.14 billion. During the same quarter in the prior year, the company posted $0.98 earnings per share. Xylem’s quarterly revenue was up 26.0% on a year-over-year basis. On average, research analysts expect that Xylem will post 4.22 EPS for the current year.
Insider Activity at Xylem
In related news, SVP Rodney Aulick sold 21,800 shares of the stock in a transaction on Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total value of $3,030,418.00. Following the completion of the sale, the senior vice president now directly owns 76,287 shares in the company, valued at approximately $10,604,655.87. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, SVP Rodney Aulick sold 21,800 shares of the company’s stock in a transaction dated Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total value of $3,030,418.00. Following the completion of the sale, the senior vice president now owns 76,287 shares of the company’s stock, valued at $10,604,655.87. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CAO Geri-Michelle Mcshane sold 2,278 shares of the business’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $138.63, for a total value of $315,799.14. Following the transaction, the chief accounting officer now directly owns 3,536 shares in the company, valued at $490,195.68. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.
Hedge Funds Weigh In On Xylem
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC boosted its stake in Xylem by 68.8% during the 1st quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock valued at $25,000 after acquiring an additional 77 shares during the last quarter. Blue Trust Inc. boosted its holdings in Xylem by 1,185.7% in the second quarter. Blue Trust Inc. now owns 270 shares of the industrial products company’s stock worth $35,000 after purchasing an additional 249 shares during the period. FinTrust Capital Advisors LLC raised its holdings in shares of Xylem by 170.9% during the first quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock worth $41,000 after purchasing an additional 200 shares during the period. Hazlett Burt & Watson Inc. lifted its position in shares of Xylem by 184.9% in the 1st quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock worth $43,000 after buying an additional 220 shares during the last quarter. Finally, UMB Bank n.a. grew its position in shares of Xylem by 96.9% during the 2nd quarter. UMB Bank n.a. now owns 382 shares of the industrial products company’s stock valued at $52,000 after buying an additional 188 shares during the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.
About Xylem
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Read More
- Five stocks we like better than Xylem
- Stock Dividend Cuts Happen Are You Ready?
- Joby Aviation Stock: The Case for Upside Just Got Stronger
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Conviction Firms for Microsoft’s Double-Digit Stock Upside
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 5 Aggressive Growth Stocks for Long-Term Investors
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.